CN
Search...
About Us
Group Overview
Management Team
Milestones of Chipscreen
Group Honors
Social Responsibility
Core Technologies and R&D
Core Technologies
Scientific Committee
R&D System
Drug Lifecycle Management
Pipeline
Pipelines
News & Events
Company News
Media Coverage
Notices & Announcements
Video Library
Investors
Company Announcements
Periodic Reports
Career Development
Contact Us
Contact Details
CN
EN
News & Events
Chipscreen Highlights: Stay Updated on Recent Hot Topics
Home
News & Events
Company News
Media Coverage
Notices & Announcements
Video Library
Select year
2026
2025
2024
2023
2022
Earlier
shown/page
5
5
10
15
20
2020.03.24
Chipscreen Biosciences's Original New Drug CS12192: Investigational New Drug (IND) Application Accepted
Chipscreen Biosciences's Original New Drug CS12192: Investigational New Drug (IND) Application Accepted
Full text
2019.12.03
National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) for Breast Cancer Indication
National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) for Breast Cancer Indication
Full text
2019.10.09
Chipscreen and Novogene enter a strategic partnership for companion diagnostics development
Chipscreen and Novogene enter a strategic partnership for companion diagnostics development
Full text
2019.09.20
Chipscreeen Biosciences’s Original New Drug Bilessglu® (for Type 2 Diabetes): Commercialization Application Accepted
Chipscreeen Biosciences’s Original New Drug Bilessglu® (for Type 2 Diabetes): Commercialization Application Accepted
Full text
2018.05.30
Good News! CHIPSCREEN BIOSCIENCES Is Approved to Be Provincial Engineering Research Center
Good News! CHIPSCREEN BIOSCIENCES Is Approved to Be Provincial Engineering Research Center
Full text
01
02
03
...
16
Media contact
（+86）0755-36993500
pr@juliucq.com
